tirzepatide constipation relief how to avoid on Tirzepatide: Evidence-Based Ozempic constipation: How to treat – Tirzepatide for Weight Loss |

In women with breast cancer and obesity or type 2 diabetes, GLP-1 receptor agonist use was associated with improved survival and lower recurrence risk in several matched comparisons

This FDA-approved drug is intended for specific medical conditions, making the path to getting prescribed both nuanced and dependent on meeting certain health criteria

For example, a 2023 study showed that in the next 3 hours after consuming carbs, there was a 65% increase in GLP-1 , which is considerably more than in the placebo group**

For a minority of people, diarrhoea may recur after dose escalations, but the pattern remains the same: temporary and improving with consistency